Polaryx Therapeutics Inc. Common Stock

PLYX | NASDAQ

$1.76

+$0.01 (+0.57%)

Nov 2, 2026, 2:47 PM ET · Market open

TTM Period Ending	TTM 2026 Jun 30, 2026	TTM 2026 Mar 31, 2026	TTM 2025 Dec 31, 2025	TTM 2025 Sep 30, 2025	TTM 2025 Jun 30, 2025	TTM 2025 Mar 31, 2025	TTM 2024 Dec 31, 2024	TTM 2023 Dec 31, 2023
PE Ratio	-22.17	-76.83	-184.21	-802.75	0	-1.01K	-218.75	-1.75K
PEG Ratio	0.47	-1.09	-9.82	-18.50	0	-1.77	-0.31	n/a
PS Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
PB Ratio	11.74	143.48	362.98	1.25K	2.04K	1.56K	1.41K	5.19K
P/FCF Ratio	-22.11	-80.40	-420.14	-2.7K	n/a	-4.22K	-2.58K	-38.31K
P/OCF Ratio	-22.11	-80.40	-420.14	-2.7K	n/a	-4.22K	-2.58K	-38.31K
OCF/S Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt / Equity Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.10
Quick Ratio	13.53	3.45	8.55	8.77	11.97	23.99	17.30	2.23
Current Ratio	13.53	3.45	8.55	8.77	11.97	23.99	17.30	2.23
Asset Turnover	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Return on Equity	-117.61%	-166.07%	-206.96%	-187.59%	-185.57%	-146.03%	-644.23%	-295.93%
Return on Assets	-57.98%	-184.95%	-165.77%	-137.27%	-213.21%	-147.50%	-607%	-163.24%
Return on Invested Capital	-37.72%	-150.09%	-135.35%	-113.75%	-180.77%	-121.59%	-92.36%	-269.11%
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a